CRI — Creotech Instruments SA Income Statement
0.000.00%
- PLN675.73m
- PLN591.70m
- PLN25.70m
Annual income statement for Creotech Instruments SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | PAS | PAS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 29.2 | 33 | 20.2 | 30.7 | 25.7 |
Cost of Revenue | |||||
Gross Profit | 23.2 | 25.3 | 10.3 | 19.1 | 17.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 27 | 32.1 | 28.9 | 47.6 | 50.5 |
Operating Profit | 2.2 | 0.985 | -8.69 | -16.9 | -24.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.23 | 0.281 | -8.78 | -17.5 | -24.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.78 | 0.475 | -7.06 | -14.3 | -20.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.78 | 0.475 | -7.06 | -14.3 | -20.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.78 | 0.475 | -7.06 | -14.3 | -20.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.11 | 0.299 | -3.99 | -6.08 | -8.6 |
Dividends per Share |